A Single Institution Experience With Pediatric Nasopharyngeal Carcinoma: High Incidence of Toxicity Associated With Platinum-based Chemotherapy Plus IMRT

Authors:
  • APArnold C. Paulino
    Arnold C. Paulino
  • SGStephen Gottschalk
    Stephen Gottschalk
  • ABAllison A. Bertuch
    Allison A. Bertuch
  • MCMurali Chintagumpala
    Murali Chintagumpala
  • HHHelen E. Heslop
    Helen E. Heslop
  • HRHeidi V. Russell
    Heidi V. Russell

Abstract
Chemotherapy and intensity-modulated radiotherapy (IMRT) have decreased treatment-related complications in adult patients with nasopharyngeal carcinoma (NPC). Our aim was to evaluate the toxicity profile of IMRT plus chemotherapy in pediatric NPC patients. Five patients were treated with chemotherapy and IMRT. All patients experienced grade 3-4 acute toxicities. With a median follow-up of 6.3 years, all patients experienced >or=3 long-term toxicities. The most common toxicities were hypothyroidism, xerostomia, hearing loss, and dental disease. We did not observe a significant decrease in long-term toxicities with IMRT plus chemotherapy in our small cohort of pediatric NPC patients.

This publication has 22 references indexed in Scilit: